PRS CK STORM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRS CK STORM, covering 2025-08-07 to 2025-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) [Phase 1, Phase 2]